Hanson & Doremus Investment Management lowered its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 54.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 58,337 shares of the biopharmaceutical